General Principles
- •
An estimated 76.4 million Americans over the age of 20 years have hypertension (HTN).
- •
HTN is the most common cardiovascular condition observed in competitive athletes.
- •
Athletes are usually considered to be free from cardiovascular disease because of their apparent high level of fitness.
- •
The overall incidence of HTN in athletes is approximately 50% less than that in the general population.
- •
Most cases are in the mild-to-moderate range.
- •
- •
HTN begins in young adulthood.
- •
Incidence increases with age.
- •
5%–10% in adults aged 20–30 years
- •
20%–35% in middle-aged adults
- •
>50% in adults aged over 60 years
- •
Residual lifetime risk of 90%
- •
- •
Almost 80% of adolescents with an elevated blood pressure (BP) (>142/92 mmHg) during preparticipation physical examinations have HTN.
- •
Classification of Hypertension (JNC-7)
- •
Progresses through three classifications ( Fig. 36.1 , Table 36.1 )
TABLE 36.1
Systolic (mmHg)
Diastolic (mmHg)
Normal
<120
<80
Prehypertension
120–139
80–89
Stage 1 hypertension
140–159
90–99
Stage 2 hypertension
≥160
≥100
- •
Normal systolic BP is <120 mmHg and diastolic BP is <80 mmHg
- •
Prehypertension systolic BP is 120–139 mmHg and diastolic BP is 80–89 mmHg.
- •
Associated with increased cardiac output (CO), which primarily increases systolic BP, along with “normal” vascular total peripheral resistance (TPR)
- •
TPR is normal compared with resting levels in normotensives but inappropriately high when CO is elevated.
- •
In a nonhypertensive patient, TPR falls to compensate for a rise in CO, thereby maintaining normal BP.
- •
Lack of decrease in TPR is a result of impaired baroreceptor function.
- •
Baroreceptors are “reset” to maintain elevated rather than normal BP over time.
- •
- •
People with prehypertension are hypersensitive to catecholamine secretion and mental stress and have a hyperkinetic circulatory state.
- •
- •
Stage 1: systolic BP 140–159 mmHg and diastolic BP 90–99 mmHg
- •
Earliest stage and most common form detected in clinical settings
- •
Increased heart rate (HR) and CO and decreased TPR
- •
Decreased arterial lumen and disturbed autoregulation of blood flow in the periphery
- •
- •
Stage 2: systolic BP >160 mmHg and diastolic BP >100 mmHg
- •
Normal HR and CO
- •
Increased TPR
- •
Increased afterload leads to left ventricular hypertrophy (LVH) and increased diastolic BP. Severe and/or uncontrolled HTN may lead to the development of diastolic dysfunction and congestive heart failure.
- •
CO can no longer increase in response to exercise or other physiologic demands.
- •
Loss of contractility and congestive heart failure may develop.
- •
- •
- •
Most active individuals with HTN will fall into stage 1 or lower stage 2 (160s/100s).
- •
Those with comorbidities, such as diabetes or renal disease, should be treated at prehypertensive levels.
- •
Values for pediatric athletes are adjusted for age, gender, and height ( Table 36.2 ).
TABLE 36.2
Normal
Systolic and diastolic BP <90th percentile
Prehypertension
Systolic and/or diastolic BP ≥90th percentile but <95th percentile, or if BP exceeds 120/80 mmHg even if <90th percentile *
Stage I hypertension
Systolic and/or diastolic BP between the 95th percentile and 5 mmHg above the 99th percentile
Stage 2 hypertension
Systolic and/or diastolic BP, 99th percentile plus 5 mmHg
* A systolic pressure of 120 mmHg may typically occur at 12 years of age, whereas a diastolic pressure of 80 mmHg typically occurs at 16 years of age.
- •
Higher stages are associated with a higher risk of nonfatal and fatal cardiovascular disease as well as progressive renal disease ( Fig. 36.2 ).
Clinical Pathophysiology of Hypertension
Primary Hypertension
- •
95% of cases
- •
Abnormal neuroreflexes and sympathetic control of peripheral resistance
- •
Abnormal renal and metabolic control of vascular volume and compliance
- •
Abnormal local smooth muscle and endothelial control of vascular resistance
- •
Sustained increases in systemic vascular resistance (SVR)
Secondary Hypertension
- •
5% of cases
- •
Younger patients or adults with rapid onset of HTN and no prior history of HTN
- •
BP is often poorly responsive to routine therapy.
Causes
- •
Renal (most common)
- •
Renovascular disease
- •
Increased renin stimulates conversion of angiotensin I to angiotensin II, which is a vasoconstrictor, as well as release of aldosterone
- •
Renal retention of sodium and water
- •
Fibromuscular dysplasia in younger patients and atherosclerosis in older patients
- •
- •
Renal parenchymal disease
- •
Inability of damaged kidneys to excrete sodium and water
- •
- •
- •
Endocrine
- •
Adrenal
- •
Pheochromocytoma
- •
Cushing syndrome
- •
Primary aldosteronism
- •
- •
Thyroid
- •
Hyperthyroidism
- •
Hypothyroidism
- •
- •
Acromegaly
- •
Hyperparathyroidism
- •
Estrogen
- •
Oral contraceptive pills (OCPs)
- •
5% will develop HTN over 5 years
- •
- •
- •
Other
- •
Coarctation of the aorta
- •
Obstructive sleep apnea
- •
Risk Factors for Hypertension
- •
Genetic factors
- •
Males more than females
- •
African-Americans more than Caucasians (2 : 1) with Asians at the lowest risk
- •
Family history (HTN twice as common if one or both parents have HTN)
- •
- •
Metabolic factors
- •
Obesity
- •
Glucose intolerance
- •
Endocrine disorders (see Causes )
- •
- •
Stress
- •
Environmental
- •
Social
- •
Leads to chronic neurogenic activation of the sympathetic nervous system
- •
- •
Behavioral factors
- •
High sodium intake
- •
Excessive alcohol consumption
- •
Drug abuse
- •
Recreational: cocaine or tobacco (chew)
- •
Ergogenic: stimulants or anabolic steroids
- •
- •
Diagnosis of Hypertension
Resting Blood Pressure (BP)
- •
Diagnosis of HTN is based on an average of two or more appropriately measured, seated BP readings >140/90 mmHg at each of two or more office visits (see Table 36.1 ).
- •
In children and adolescents, HTN is defined as average systolic or diastolic BP ≥95th percentile for age, gender, and height, measured on three separate occasions (see Table 36.2 ).
Environment During Measurement
- •
Measurement of BP should be performed in a standard measurement situation, preferably a quiet area.
- •
Let the athlete sit for a few minutes if possible.
- •
Repeat BP measurements if elevated.
- •
Choose the appropriate-size BP cuff. Several athletes will need a large cuff, and a thigh cuff should be available for very large athletes.
- •
The inflatable bag of the BP cuff should cover approximately 80% of the arm’s circumference.
- •
BP may be overestimated if the BP cuff is too small, while BP may be underestimated if the BP cuff is too big.
- •
- •
Avoid rapid deflation of the cuff.
“White Coat” Hypertension and Other Stress Phenomena
- •
Anxiety provoked by medical examination or other sources of mental stress can lead to artificially elevated BP, known as “white coat” HTN.
- •
Average of several readings is a better estimate of true BP.
- •
If initial BP is high, have the athlete rest for 5 minutes and repeat BP measurement.
- •
If BP remains elevated, check BP at least once per week for at least two additional visits.
- •
Averaged daily BP is a better predictor of later end-organ damage than random office BP.
- •
Ambulatory 24-hour BP monitoring (ABPM) may more accurately assess BP in people with variable readings in the office or at home.
- •
Home BP monitoring is readily available and correlates well with ABPM.
- •
Importance of accurate readings should be emphasized.
Clinical Evaluation
History
- •
Cardiovascular risk factors:
- •
Smoking
- •
Family history of cardiac disease in men younger than 55 years and women younger than 65 years
- •
Obesity
- •
Physical inactivity
- •
Diabetes
- •
Dyslipidemia
- •
- •
Diet and behavior:
- •
High sodium and saturated fat intake
- •
Alcohol consumption
- •
Herbs and supplements (particularly those for energy or weight loss)
- •
Drug use
- •
Over the counter (nonsteroidal anti-inflammatory drugs [NSAIDs], decongestants, caffeine, and diet pills)
- •
Prescription (glucocorticosteroids, erythropoietin, cyclosporine, methylphenidates, and amphetamines)
- •
Illicit (ergogenic aids, cocaine, and phencyclidine [PCP])
- •
- •
- •
Stress
- •
Review of systems to rule out secondary causes of HTN
Physical Examination
- •
Evaluate for secondary causes of HTN and end-organ damage
- •
Body mass index (BMI) often not useful in athletes because of higher levels of muscle mass
- •
Fundoscopic examination for retinopathy, as indicated by retinal hemorrhages or exudates, with or without papilledema ( Fig. 36.3 )
- •
Thyroid
- •
Cardiovascular (pulses, murmurs, and bruits)
- •
Abdominal masses
- •
Peripheral edema
Laboratory Studies
- •
Hematocrit, Na+, K+, BUN, creatinine, glucose, lipid panel, urinalysis, EKG
- •
Further workup if suspicious of secondary causes
- •
Renal ultrasound recommended for pediatric athletes with established HTN
- •
Echocardiogram recommended in pediatric athletes with diabetes or renal disease associated with a BP between the 90 th and 94 th percentiles and all children with stage 2 HTN and BP in the ≥95 th percentile
- •
Exercise Stress Testing
- •
Although not routinely performed, exercise stress testing can be used to predict and differentiate types of HTN .
- •
Differentiating stages of HTN
- •
People with prehypertension start at higher resting levels than normotensives but do not show abnormally high BP levels during maximal exercise.
- •
Rapid elevation in systolic BP indicates established HTN.
- •
Hypertensives tend to have increased diastolic BP during and after exercise.
- •
- •
Predicting future HTN
- •
Exaggerated diastolic BP response to exercise (>95 th percentile) predicts the risk of new-onset HTN in men and women (2–4 times higher risk).
- •
Delayed recovery of systolic BP response is predictive of future HTN in men.
- •
Exercise BP may be a significant predictor of adverse cardiovascular events in high-risk patients.
- •